Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
M. Perez Morales (Cádiz, Spain), C. España Domínguez (Cádiz, Spain), M. Morales González (Cádiz, Spain), I. Muñoz Ramírez (Cádiz, Spain), M. Merino Sánchez (Cádiz, Spain), A. Arnedillo Muñoz (Cádiz, Spain). Characteristics of patients treated with nicotine replacement therapy (NRT) prescribed during hospitalization. 2862

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011 Patients perceptions of nicotine replacement therapy (NRT) and smoking cessation services available in their area Source: Eur Respir J 2001; 18: Suppl. 33, 167s Year: 2001 Nicotine replacement therapy in ICU patients Source: Annual Congress 2012 - Treatment of tobacco dependence as a treatment of lung diseases Year: 2012 Effect of treatment for nicotine dependence using bupropion therapy in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 283s Year: 2007 Cost consequences of tiotropium plus existing therapy versus existing therapy alone following one year of treatment in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 5s Year: 2001 Characteristics of patients receiving inhaled treatment in primary care Source: Annual Congress 2009 - Respiratory physiology Year: 2009 How often do asthma patients claim prescribed therapy? Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS Year: 2017 Effect of ICS withdrawal on COPD exacerbations in patients on triple therapy at baseline Source: International Congress 2018 – COPD management Year: 2018 Budesonide/formoterol for maintenance and relief vs. higher dose ICS/LABA therapy: outcomes in patients symptomatic on high-dose inhaled corticosteroids (HDICS) Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment Year: 2007 Improvement of quit smoking rate by combining varenicline and nicotine replacement therapy Source: Annual Congress 2009 - Smoking cessation Year: 2009 Comparison of hospitalization risk for Medicaid patients with COPD by medication regimen Source: Eur Respir J 2003; 22: Suppl. 45, 375s Year: 2003 Characteristics and treatment pathways of patients with COPD receiving an inhaled corticosteroid/long-acting ß2-agonist (ICS/LABA) in the UK Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Addition of tiotropium (T) to a regular treatment with long-acting β-agonist+inhaled corticosteroid (LABA+ICS) in patients with severe to very-severe COPD under in-patient pulmonary rehabilitation program (PRP) Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease Year: 2009 Higher effectiveness of a longer course of nicotine replacement therapy for smoking cessation Source: Eur Respir J 2006; 28: Suppl. 50, 296s Year: 2006 Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 Clinical and economic impact of inhaled corticosteroid withdrawal in Spanish COPD patients treated with triple therapy Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 High-dose inhaled corticosteroids and add-on therapy use in adults in the UK: an observational study of 22,027 patients Source: Annual Congress 2004 - Primary care: asthma Year: 2004 The use of high-dose inhaled corticosteroids and add-on therapy in children in the UK: an observational study of 4332 patients Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma Year: 2004 Inhaled corticosteroids and survival in patients with COPD receiving long-term home oxygen therapy Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005 Duration of therapy in hospitalised patients with CAP Source: Annual Congress 2007 - An international perspective of the management of hospitalised patients with community-acquired pneumonia Year: 2007